Perigon Wealth Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
Perigon Wealth Management's WST Position: Q3 2026 in Review
Perigon Wealth Management increased its West Pharmaceutical (WST) stake by 11% in Q3 2026, buying an estimated $71.7K and bringing the position to 2,071 shares worth $768K. The position accounts for 0.01% of the portfolio, ranked #695.
Perigon Wealth Management first reported a position in WST in Q4 2020 and has held it in 17 quarters since. 189 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- Perigon Wealth Management held 2,071 shares of West Pharmaceutical worth $768K as of Q3 2026.
- Perigon Wealth Management bought 203 West Pharmaceutical shares in Q3 2026, an estimated $71.7K.
- West Pharmaceutical made up 0.01% of Perigon Wealth Management's portfolio in Q3 2026, its #695 holding.
- Perigon Wealth Management first reported a position in West Pharmaceutical in Q4 2020 and has held it in 17 quarters since.
- 189 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on Perigon Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.